Additional file 1 of Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country

Autor: Muntañola, Ana, Villacampa, Guillermo, Hernández-Rivas, José Ángel, Alonso, Rosalía, Mirás, Fátima, Osorio, Santiago, Baile, Mónica, Baltasar, Patricia, Jiménez, Javier López, Hernandez-Rodriguez, Ines, Valenciano, Susana, Alfayate, Ana, Gimeno, Eva, Bárez, Abelardo, Oliveira, Ana C., Riaza, Rosalía, Romero, Pilar, Delgado, Julio, Lucrecia Yáñez, Zabalza, Amaya, Torres, Ana, Mª Isabel Gómez-Roncero, Crespo, Marta, Córdoba, Raúl, Mateos-Mazón, Juan José, Pérez, Sonia, Andreu, Rafael, Labrador, Jorge, Mª Elena Ruiz, Velasquez, César Andrés, Mª José Terol, Santiago, Raquel, Mª Jesús Vidal, Fiz Campoy García, Villalón, Lucía, Muiña, Begoña S., Soler, Joan Alfons, Seri, Cristina, Mª José Sánchez, Cuesta, Amalia, Ramos, Rafael, Sánchez-Montalvá, Adrián, Ruiz-Camps, Isabel, González, Marcos, Abrisqueta, Pau, Bosch, Francesc

Additional file 1: Table S1. Patient and CLL features at the time of COVID-19 infection (n = 165). Table S2. COVID-19 manifestations, management, and outcomes. Table S3. Univariate and multivariate OS analysis of baseline characteristics. Table S4. C

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65cddc964e7901a9129af310507d63b6

Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country.

Autor: Muntañola A; Hospital Universitari Mútua Terrassa, Barcelona, Spain., Villacampa G; Oncology Data Science, Vall D'Hebron Institute of Oncology, Barcelona, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain., Hernández-Rivas JÁ; Hospital Universitario Infanta Leonor, Madrid, Spain., Alonso R; Hospital Universitario Puerta de Hierro, Madrid, Spain., Mirás F; Hospital Universitario 12 de Octubre, Madrid, Spain., Osorio S; Hospital Universitario Gregorio Marañón/Gregorio Marañón Health Institute (IiSGM), Madrid, Spain., Baile M; Hospital Universitario de Salamanca/IBSAL, CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain., Baltasar P; Hospital Universitario La Paz, Madrid, Spain., López Jiménez J; Hospital Universitario Ramón y Cajal, Madrid, Spain., Hernandez-Rodriguez I; Hospital Germans Trias i Pujol-ICO Badalona, Barcelona, Spain., Valenciano S; Hospital Universitario Príncipe de Asturias, Madrid, Spain., Alfayate A; Hospital Clínico San Carlos, Madrid, Spain., Gimeno E; Hospital del Mar, Barcelona, Spain., Bárez A; Complejo Asistencial de Ávila, Ávila, Spain., Oliveira AC; Hospital Duran i Reynals-ICO Hospitalet, Barcelona, Spain., Riaza R; Hospital Universitario Severo Ochoa, Madrid, Spain., Romero P; Hospital Universitario Donostia, San Sebastián, Spain., Delgado J; Hospital Clínic de Barcelona, Barcelona, Spain., Yáñez L; Hospital Universitario Marqués de Valdecilla, Santander, Spain., Zabalza A; Complejo Hospitalario de Navarra, Pamplona, Spain., Torres A; Complejo Asistencial de Segovia, Segovia, Spain., Gómez-Roncero MI; Hospital Virgen de la Salud, Toledo, Spain., Crespo M; Department of Hematology, Vall d'Hebron Barcelona Hospital Campus, Passeig de la Vall d'Hebron, 119-129, 08035, Barcelona, Spain., Córdoba R; Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Mateos-Mazón JJ; Hospital Universitario de Cruces, Barakaldo, Spain., Pérez S; Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Andreu R; Hospital Universitario La Fe de Valencia, Valencia, Spain., Labrador J; Hospital Universitario de Burgos, Burgos, Spain., Ruiz ME; Hospital Universitario del Tajo, Madrid, Spain., Velasquez CA; Hospital de Mollet, Barcelona, Spain., Terol MJ; Hospital Clínico Universitario de Valencia, Valencia, Spain., Santiago R; Hospital Sant Joan de Déu de Manresa - Fundació ALTHAIA, Barcelona, Spain., Vidal MJ; Hospital Universitario de León, León, Spain., Campoy García F; Complexo Hospitalario Universitario de Ourense, Ourense, Spain., Villalón L; Hospital Universitario Fundación Alcorcón, Madrid, Spain., Muiña BS; Hospital Rafael Méndez de Lorca, Murcia, Spain., Soler JA; Consorci Corporació Sanitària Parc Taulí de Sabadell, Barcelona, Spain., Seri C; Hospital Central de la Defensa Gómez Ulla, Madrid, Spain., Sánchez MJ; Hospital Universitario Lucus Augusti, Lugo, Spain., Cuesta A; Hospital Sierrallana (Torrelavega), Cantabria, Spain., Ramos R; Hospital Universitario de Badajoz, Badajoz, Spain., Sánchez-Montalvá A; Department of Hematology, Vall d'Hebron Barcelona Hospital Campus, Passeig de la Vall d'Hebron, 119-129, 08035, Barcelona, Spain., Ruiz-Camps I; Department of Hematology, Vall d'Hebron Barcelona Hospital Campus, Passeig de la Vall d'Hebron, 119-129, 08035, Barcelona, Spain., González M; Hospital Universitario de Salamanca/IBSAL, CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain., Abrisqueta P; Department of Hematology, Vall d'Hebron Barcelona Hospital Campus, Passeig de la Vall d'Hebron, 119-129, 08035, Barcelona, Spain. pabrisqueta@vhio.net., Bosch F; Department of Hematology, Vall d'Hebron Barcelona Hospital Campus, Passeig de la Vall d'Hebron, 119-129, 08035, Barcelona, Spain.

Publikováno v: Experimental hematology & oncology [Exp Hematol Oncol] 2020 Dec 18; Vol. 9 (1), pp. 37. Date of Electronic Publication: 2020 Dec 18.